Merck
MRK
#51
Rank
S$378.90 B
Marketcap
S$153.42
Share price
-0.43%
Change (1 day)
48.39%
Change (1 year)

EPS for Merck (MRK)

EPS in 2026 (TTM): S$4.56

According to Merck's latest financial reports the company's current EPS (TTM) is S$4.58. In 2025 the company made an earnings per share (EPS) of S$9.39 an increase over its 2024 EPS that were of S$8.71.

EPS history for Merck from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S$4.56-51.45%
2025S$9.397.81%
2024S$8.714308.46%
2023S$0.20-97.32%
2022S$7.3810.92%
2021S$6.6584.68%
2020S$3.60-27.2%
2019S$4.9563.44%
2018S$3.03151.11%
2017S$1.21-54.58%
2016S$2.6530.21%
2015S$2.04-61.99%
2014S$5.36180.51%
2013S$1.91-31.82%
2012S$2.806.62%
2011S$2.63

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
S$11.25 145.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$9.04 97.34%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$1.69-63.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
S$4.65 1.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$36.36 693.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$18.65 307.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$3.30-28.05%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
S$4.59 0.07%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$5.01 9.25%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
S$1.76-61.49%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel